The thousand doors that lead to death: p53-Dependent repression and apoptosis

Cancer Biology and Therapy

Volumn 2, Issue 4, 2003, Pages 381-382

  Murphy, Maureen E ^a  

^a NONE

Author keywords

Clusterin; Ionizing radiation; p53

Indexed keywords

ANTINEOPLASTIC AGENT; CHAPERONE; CLU PROTEIN, HUMAN; CLUSTERIN; COMPLEMENT INHIBITOR; GLYCOPROTEIN; MESSENGER RNA; PROTEIN P53; TUMOR PROTEIN;

APOPTOSIS; CYTOPLASM; DNA DAMAGE; DRUG ANTAGONISM; DRUG EFFECT; EDITORIAL; GAMMA RADIATION; GENETIC TRANSCRIPTION; GENETICS; HUMAN; METABOLISM; NEOPLASM; PATHOLOGY; PHYSIOLOGY; PROMOTER REGION; RADIATION EXPOSURE;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CLUSTERIN; COMPLEMENT INACTIVATOR PROTEINS; CYTOPLASM; DNA DAMAGE; GAMMA RAYS; GLYCOPROTEINS; HUMANS; MOLECULAR CHAPERONES; NEOPLASM PROTEINS; NEOPLASMS; PROMOTER REGIONS (GENETICS); RNA, MESSENGER; TRANSCRIPTION, GENETIC; TUMOR SUPPRESSOR PROTEIN P53;

EID: 25444469598     PISSN: 15384047     EISSN: 15558576     Source Type: Journal    
DOI: 10.4161/cbt.2.4.439     Document Type: Note

References (15)

1. Bunz F, Dutriaux A, Lengauer C, Waldman T, Zhou S, Brown JP, Sedivy JM, Kinzler KW, Vogelstein B. Requirement for p53 and p21 to sustain G2 arrest after DNA damage. Science 1998; 282:1497-501. (Pubitemid 28538613)
2. Vousden KH, Lu X. Live or let die: the cell's response to p53. Nat Rev Cancer 2002; 2:594-604. (Pubitemid 37328926)
3. Mihara M, Erster S, Zaika A, Petrenko O, Chittenden T, Pancoska P, Moll UM. p53 has a direct apoptogenic role at the mitochondria. Mol Cell 2003; 11:577-90. (Pubitemid 36385115)
4. Jones SE, Jomary C. Clusterin. Int J Biochem Cell Biol 2002; 34:427-31.
5. Wilson MR, Easterbrook-Smith SB. Clusterin is a secreted mammalian chaperone. Trends Biochem Sci. 2000; 25:95-8. (Pubitemid 30122416)
6. Hough CD, Cho KR, Zonderman AB, Schwartz DR, Morin PJ. Coordinately up-regulated genes in ovarian cancer. Cancer Res 2001; 61:3869-76. (Pubitemid 32720943)
7. Steinberg J, Oyasu R, Lang S, Sintich S, Rademaker A, Lee C, Kozlowski JM, Sensibar JA. Intracellular levels of SGP-2 (Clusterin) correlate with tumor grade in prostate cancer. Clin Cancer Res. 1997; 3:1707-11. (Pubitemid 27444708)
8. Sakamuro D, Sabbatini P, White E, Prendergast GC. The polyproline region of p53 is required to activate apoptosis but not growth arrest. Oncogene. 1997; 15:887-98. (Pubitemid 27399550)
9. Venot C, Maratrat M, Dureuil C, Conseiller E, Bracco L, Debussche L. The requirement for the p53 proline-rich functional domain for mediation of apoptosis is correlated with specific PIG3 gene transactivation and with transcriptional repression. EMBO J 1998; 17:4668-79. (Pubitemid 28377167)
10. Mack DH, Vartikar J, Pipas JM, Laimins LA. Specific repression of TATA-mediated but not initiator-mediated transcription by wild-type p53. Nature 1993; 363:281-3. (Pubitemid 23158535)
11. Lohr K, Moritz C, Contente A, Dobbelstein M. p21/CDKN1A mediates negative regulation of transcription by p53. J Biol Chem 2003; [Epub ahead of print].
12. Murphy M, Hinman A, Levine AJ. Wild-type p53 negatively regulates the expression of a microtubule-associated protein. Genes Dev 1996; 10:2971-80. (Pubitemid 26412524)
13. Yang CR, Leskov K, Hosley-Eberlein K, Criswell T, Pink JJ, Kinsella TJ, Boothman DA. Nuclear clusterin/XIP8, an x-ray-induced Ku70-binding protein that signals cell death. Proc Natl Acad Sci USA 2000; 97:5907-12. (Pubitemid 30367497)
14. Leskov KS, Klokov DY, Li J, Kinsella TJ, Boothman DA. Synthesis and functional analyses of nuclear clusterin, a cell death protein. J Biol Chem. 2003; 278:11590-600. (Pubitemid 36792721)
15. Jiang ZH, Wu JY. Alternative splicing and programmed cell death. Proc Soc Exp Biol Med. 1999; 220:64-72.